Metabolic Disorder Therapeutics Market

Metabolic Disorder Therapeutics Market aims to provide a comprehensive presentation of the global market for Metabolic Disorder Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabolic Disorder Therapeutics. Metabolic Disorder Therapeutics Market contains market size and forecasts of Metabolic Disorder Therapeutics in global, including the following market information:
Global Metabolic Disorder Therapeutics Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Metabolic Disorder Therapeutics market was valued at US$ 48030 million in 2022 and is projected to reach US$ 63690 million by 2029, at a CAGR of 4.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Increasing demand for one-time therapies for metabolic disorders and rising prevalence of lifestyle diseases are the key factors that are expected to boost the growth of this market.
We surveyed the Metabolic Disorder Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Metabolic Disorder Therapeutics Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Metabolic Disorder Therapeutics Market Segment Percentages, by Type, 2022 (%)
Lysosomal Storage Diseases
Diabetes
Obesity
Inherited Metabolic Disorders
Hypercholesterolemia
Global Metabolic Disorder Therapeutics Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Metabolic Disorder Therapeutics Market Segment Percentages, by Application, 2022 (%)
Oral
Parenteral
Others
Global Metabolic Disorder Therapeutics Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Metabolic Disorder Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Metabolic Disorder Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Metabolic Disorder Therapeutics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk A/S
Sanofi S.A.
Boehringer Ingelheim GmbH
Eli Lilly and Company
Merck KgaA
Amgen, Inc.
AstraZeneca PLC
Actelion Pharmaceuticals Ltd.
Shire PLC
AbbVie, Inc.
Biocon Ltd.
BioMarin Pharmaceutical, Inc.
Bristol-Myers Squibb Company
Cipla, Inc.
CymaBay Therapeutics, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Metabolic Disorder Therapeutics, market overview.
Chapter 2: Global Metabolic Disorder Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Metabolic Disorder Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Metabolic Disorder Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.